10-Q Filing

AGIOS PHARMACEUTICALS, INC. CIK: 1439222 Q1 2023

Filing Information

Form Type	10-Q
Accession Number	`0001439222-23-000065`
Period End Date	20230331
Filing Date	20230504
Fiscal Year	2023
Fiscal Period	Q1
XBRL Instance	agio-20230331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 72 Income Statement 28 Cash Flow Statement 62 Stockholders Equity 21 Comprehensive Income 6

Balance Sheet 72 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$104.14M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$139.26M	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$635.06M	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$643.86M	USD	Point-in-time
Common stock, par value (in usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable, net	`ContractWithCustomerAssetNetCurrent`	$1.78M	USD	Point-in-time
Accounts receivable, net	`ContractWithCustomerAssetNetCurrent`	$2.21M	USD	Point-in-time
Inventory	`InventoryNet`	$8.49M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	125.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	125.00M	shares	Point-in-time
Inventory	`InventoryNet`	$11.37M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	71.26M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$39.30M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	71.76M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$38.95M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	55.04M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$832.77M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$791.66M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	55.54M	shares	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesNoncurrent`	$271.73M	USD	Point-in-time
Treasury stock, shares (in shares)	`TreasuryStockShares`	16.22M	shares	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesNoncurrent`	$313.87M	USD	Point-in-time
Treasury stock, shares (in shares)	`TreasuryStockShares`	16.22M	shares	Point-in-time
Operating lease assets	`OperatingLeaseRightOfUseAsset`	$65.13M	USD	Point-in-time
Operating lease assets	`OperatingLeaseRightOfUseAsset`	$62.52M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$22.99M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$21.44M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$3.96M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$3.96M	USD	Point-in-time
Total assets	`Assets`	$1.24B	USD	Point-in-time
Total assets	`Assets`	$1.15B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$8.66M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$18.62M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$30.35M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$22.46M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$13.66M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$13.99M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$45.11M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$62.63M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$68.35M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$72.00M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$3.28M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$1.31M	USD	Point-in-time
Total liabilities	`Liabilities`	$114.77M	USD	Point-in-time
Total liabilities	`Liabilities`	$137.90M	USD	Point-in-time
Preferred stock, $0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at March 31, 2023 and December 31, 2022	`PreferredStockValueOutstanding`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at March 31, 2023 and December 31, 2022	`PreferredStockValueOutstanding`	-	USD	Point-in-time
Common stock, $0.001 par value; 125,000,000 shares authorized; 71,757,778 shares issued and 55,541,367 shares outstanding at March 31, 2023, and 71,256,118 shares issued and 55,039,707 shares outstanding at December 31, 2022	`CommonStockValueOutstanding`	$71.00K	USD	Point-in-time
Common stock, $0.001 par value; 125,000,000 shares authorized; 71,757,778 shares issued and 55,541,367 shares outstanding at March 31, 2023, and 71,256,118 shares issued and 55,039,707 shares outstanding at December 31, 2022	`CommonStockValueOutstanding`	$72.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.40B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.39B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-12.54M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-8.41M	USD	Point-in-time
Treasury stock, at cost (16,216,411 shares at March 31, 2023 and December 31, 2022)	`TreasuryStockValue`	$802.49M	USD	Point-in-time
Treasury stock, at cost (16,216,411 shares at March 31, 2023 and December 31, 2022)	`TreasuryStockValue`	$802.49M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-470.56M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-551.58M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.29B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.21B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.10B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.04B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$1.15B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$1.24B	USD	Point-in-time

Income Statement 28 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$832.00K	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$5.61M	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$554.00K	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$339.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$67.30M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$70.12M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$28.37M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$31.52M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$96.22M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$101.98M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-101.14M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-90.61M	USD	1 Quarter
Royalty income from gain on sale of oncology business	`RoyaltyIncomeNonoperating`	$2.70M	USD	1 Quarter
Royalty income from gain on sale of oncology business	`RoyaltyIncomeNonoperating`	-	USD	1 Quarter
Interest income, net	`InvestmentIncomeNet`	$694.00K	USD	1 Quarter
Interest income, net	`InvestmentIncomeNet`	$8.09M	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$2.97M	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$1.50M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-94.77M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-81.02M	USD	1 Quarter
Net (loss) income per share - basic (in usd per share)	`EarningsPerShareBasic`	$-1.74	USD	1 Quarter
Net (loss) income per share - basic (in usd per share)	`EarningsPerShareBasic`	$-1.47	USD	1 Quarter
Net (loss) income per share - diluted (in usd per share)	`EarningsPerShareDiluted`	$-1.47	USD	1 Quarter
Net (loss) income per share - diluted (in usd per share)	`EarningsPerShareDiluted`	$-1.74	USD	1 Quarter
Weighted-average number of common shares used in computing net loss per share from continuing operations, net (loss) income from discontinued operations and net (loss) income per share - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	54.56M	shares	1 Quarter
Weighted-average number of common shares used in computing net loss per share from continuing operations, net (loss) income from discontinued operations and net (loss) income per share - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	55.27M	shares	1 Quarter
Weighted-average number of common shares used in computing net loss per share from continuing operations, net (loss) income from discontinued operations and net (loss) income per share - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	54.56M	shares	1 Quarter
Weighted-average number of common shares used in computing net loss per share from continuing operations, net (loss) income from discontinued operations and net (loss) income per share - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	55.27M	shares	1 Quarter

Cash Flow Statement 62 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-94.77M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-81.02M	USD	1 Quarter
Depreciation and amortization	`OtherDepreciationAndAmortization`	$2.48M	USD	1 Quarter
Depreciation and amortization	`OtherDepreciationAndAmortization`	$1.79M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$10.14M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$15.51M	USD	1 Quarter
Net amortization of premium (accretion of discount) on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-1.15M	USD	1 Quarter
Net amortization of premium (accretion of discount) on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$2.78M	USD	1 Quarter
Gain on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$150.00K	USD	1 Quarter
Gain on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	1 Quarter
Non-cash operating lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$2.44M	USD	1 Quarter
Non-cash operating lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$2.61M	USD	1 Quarter
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$540.00K	USD	1 Quarter
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$-428.00K	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	$2.88M	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	$2.48M	USD	1 Quarter
Other receivables	`IncreaseDecreaseInOtherReceivables`	-	USD	1 Quarter
Other receivables	`IncreaseDecreaseInOtherReceivables`	$987.00K	USD	1 Quarter
Prepaid expenses and other current and non-current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$348.00K	USD	1 Quarter
Prepaid expenses and other current and non-current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$3.39M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-5.01M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-9.80M	USD	1 Quarter
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-7.89M	USD	1 Quarter
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-12.22M	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	-	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$2.50M	USD	1 Quarter
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-2.40M	USD	1 Quarter
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-3.32M	USD	1 Quarter
Other non-current liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-1.97M	USD	1 Quarter
Other non-current liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	-	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-97.73M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-95.18M	USD	1 Quarter
Purchases of marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$355.92M	USD	1 Quarter
Purchases of marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$128.35M	USD	1 Quarter
Proceeds from maturities and sales of marketable securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$186.20M	USD	1 Quarter
Proceeds from maturities and sales of marketable securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$332.15M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$399.00K	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.80M	USD	1 Quarter
Proceeds from sale of equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$150.00K	USD	1 Quarter
Proceeds from sale of equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-26.57M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$57.60M	USD	1 Quarter
Payments on financing lease obligations	`FinanceLeasePrincipalPayments`	$81.00K	USD	1 Quarter
Payments on financing lease obligations	`FinanceLeasePrincipalPayments`	-	USD	1 Quarter
Net proceeds from stock option exercises and employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$2.47M	USD	1 Quarter
Net proceeds from stock option exercises and employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$1.29M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.47M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.21M	USD	1 Quarter
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-35.12M	USD	1 Quarter
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-123.10M	USD	1 Quarter
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$104.14M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$139.26M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$80.03M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$203.13M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$104.14M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$139.26M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$80.03M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$203.13M	USD	Point-in-time
Additions to property and equipment in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	-	USD	1 Quarter
Additions to property and equipment in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$1.54M	USD	1 Quarter
Cash taxes paid	`IncomeTaxesPaid`	$1.84M	USD	1 Quarter
Cash taxes paid	`IncomeTaxesPaid`	-	USD	1 Quarter

Stockholders Equity 21 line items

Line Item	Tag	Value	Unit	Period
Common stock, beginning balance (in shares)	`CommonStockSharesOutstanding`	55.04M	shares	Point-in-time
Common stock, beginning balance (in shares)	`CommonStockSharesOutstanding`	55.54M	shares	Point-in-time
Beginning balance	`StockholdersEquity`	$1.29B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$1.21B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$1.10B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$1.04B	USD	Point-in-time
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax`	$-6.55M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax`	$4.12M	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	131,486.00	shares	1 Quarter
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.47M	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.29M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$15.51M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$10.14M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-94.77M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-81.02M	USD	1 Quarter
Common stock, ending balance (in shares)	`CommonStockSharesOutstanding`	55.04M	shares	Point-in-time
Common stock, ending balance (in shares)	`CommonStockSharesOutstanding`	55.54M	shares	Point-in-time
Ending balance	`StockholdersEquity`	$1.29B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$1.21B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$1.10B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$1.04B	USD	Point-in-time

Comprehensive Income 6 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-94.77M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-81.02M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-6.55M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$4.12M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-76.89M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-101.32M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.